Modified cyclosporine which can be used as a pro-drug and use thereof

Details for Australian Patent Application No. 2002245996 (hide)

Owner Debiopharm S.A.

Inventors HamelL, Arnaud; Hubler, Francis; Wenger, Roland; Mutter, Manfred

Agent Spruson & Ferguson

Pub. Number AU-B-2002245996

PCT Pub. Number WO2002/085928

Priority 720/01 20.04.01 CH

Filing date 22 April 2002

Wipo publication date 5 November 2002

Acceptance publication date 30 June 2005

International Classifications

C07K 007/64 Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 038/13 Medicinal preparations containing peptides

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002245996

30 June 2005 Application Accepted

  Published as AU-B-2002245996

14 July 2005 Corrigenda

  Applications Accepted - Name Index Under the name Debiopharm S.A., Application No. 2002245996, under INID (72) correct the inventor name to read Hamel, Arnaud.

27 October 2005 Standard Patent Sealed

10 July 2008 Assignment Registered

  Debiopharm S.A. The patent has been assigned to Ophthalmopharma AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245997-METHOD FOR DIE CASTING AND A CORRESPONDING DIE CASTING MACHINE

2002245995-DEVICE AND METHOD FOR PURIFYING OUTGOING AIR WHICH IS LOADED WITH CONTAMINANTS